Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Cisatracurium Besylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 36,786Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Health Canada Issues Recalls of Cisatracurium Besylate Inj
    Health Canada Issues Recalls of Cisatracurium Besylate Inj

    18 Feb 2025

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/cisatracurium-besylate-injection-usp-multidose-level-degradation-product-benzaldehyde

    HEALTH CANADA
    18 Feb 2025
    Share Share
    Hainan Poly`s Generics Cisatracurium Besylate Receives Approval in US
    Hainan Poly`s Generics Cisatracurium Besylate Receives Approval in US

    27 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216539

    FDA
    27 Aug 2024
    Share Share
    Hainan Poly`s Generic Cisatracurium Besylate Receives Approval in the U.S.
    Hainan Poly`s Generic Cisatracurium Besylate Receives Approval in the U.S.

    08 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216538

    FDA
    08 Mar 2024
    Share Share
    Caplin's Generic Cisatracurium Besylate Receives Approval in the U.S.
    Caplin's Generic Cisatracurium Besylate Receives Approval in the U.S.

    09 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217725

    FDA
    09 Jun 2023
    Share Share
    Development Of Manufacturing Technology For Three Pharmaceutical Ingredients
    Development Of Manufacturing Technology For Three Pharmaceutical Ingredients

    30 Jan 2023

    // PRESS RELEASE

    http://cfpharma.hu/development-of-manufacturing-technology-for-three-pharmaceutical-ingredients/

    PRESS RELEASE
    30 Jan 2023
    Share Share
    Piramal's Generic Cisatracurium Besylate Receives Approval in the U.S.
    Piramal's Generic Cisatracurium Besylate Receives Approval in the U.S.

    11 Mar 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212432

    FDA
    11 Mar 2022
    Share Share